R Mesa. Pegylated interferon for the treatment of high-risk essential thrombocythemia. Haematologica 2005;90(10):1298B-1298B; https://doi.org/10.3324/%x.
To create an adaptation, translation, or derivative of the
original work, for commercial e-prints and printed articles further permission is
required. For
information contact: marketing@haematologica.org
Other types of copyright management, can be agreed with the Editorial office.
